Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $9.89 Million - $11.1 Million
-54,500 Closed
0 $0
Q2 2021

Nov 08, 2023

BUY
$187.49 - $221.1 $10.2 Million - $12 Million
54,500 New
54,500 $11 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $10.2 Million - $12 Million
54,500 New
54,500 $11 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $14.6 Million - $18.1 Million
-73,009 Closed
0 $0
Q4 2019

Nov 08, 2023

BUY
$166.71 - $223.91 $3.68 Million - $4.95 Million
22,100 Added 43.41%
73,009 $16 Million
Q4 2019

Feb 13, 2020

BUY
$166.71 - $223.91 $3.68 Million - $4.95 Million
22,100 Added 43.41%
73,009 $16 Million
Q3 2019

Nov 08, 2023

SELL
$166.23 - $187.09 $1.15 Million - $1.3 Million
-6,940 Reduced 12.0%
50,909 $8.63 Million
Q3 2019

Nov 13, 2019

SELL
$166.23 - $187.09 $1.15 Million - $1.3 Million
-6,940 Reduced 12.0%
50,909 $8.63 Million
Q2 2019

Nov 08, 2023

BUY
$164.61 - $190.37 $3.23 Million - $3.74 Million
19,620 Added 51.32%
57,849 $10.6 Million
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $3.23 Million - $3.74 Million
19,620 Added 51.32%
57,849 $10.6 Million
Q1 2019

Nov 08, 2023

BUY
$163.73 - $194.7 $284,399 - $338,193
1,737 Added 4.76%
38,229 $7.03 Million
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $284,399 - $338,193
1,737 Added 4.76%
38,229 $7.03 Million
Q4 2018

Nov 08, 2023

SELL
$151.91 - $192.21 $1.76 Million - $2.23 Million
-11,600 Reduced 24.12%
36,492 $6.05 Million
Q4 2018

Feb 13, 2019

SELL
$151.91 - $192.21 $1.76 Million - $2.23 Million
-11,600 Reduced 24.12%
36,492 $6.05 Million
Q3 2018

Nov 08, 2023

BUY
$167.73 - $192.74 $2.23 Million - $2.56 Million
13,270 Added 38.11%
48,092 $9.27 Million
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $2.23 Million - $2.56 Million
13,270 Added 38.11%
48,092 $9.27 Million
Q2 2018

Nov 08, 2023

SELL
$145.72 - $169.96 $1.46 Million - $1.7 Million
-10,000 Reduced 22.31%
34,822 $5.92 Million
Q2 2018

Aug 14, 2018

SELL
$145.72 - $169.96 $1.46 Million - $1.7 Million
-10,000 Reduced 22.31%
34,822 $5.92 Million
Q1 2018

Nov 08, 2023

BUY
$151.6 - $177.13 $6.8 Million - $7.94 Million
44,822 New
44,822 $7.31 Billion
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $2.02 Million - $2.36 Million
-13,300 Reduced 22.88%
44,822 $7.31 Million
Q4 2017

Nov 08, 2023

BUY
$137.28 - $155.55 $7.98 Million - $9.04 Million
58,122 New
58,122 $8.71 Billion
Q4 2017

Feb 13, 2018

BUY
$137.28 - $155.55 $7.98 Million - $9.04 Million
58,122
58,122 $8.71 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.